Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2011PTC073540 Incorporated 28 March 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare
Revenue · FY 2020
₹37.41 Lakh
▲ 5% YoY
Net loss · FY 2020
₹5,616
Net margin -0.2%
EBITDA · FY 2020
₹24,928
EBITDA margin 0.7%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Claro Pharmaceuticals Private Limited

Data last updated:

Claro Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073540. Its GSTIN is 36AAECC4747M1ZA (Telangana).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chevuru Hariprasad and Arun Singh.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.

As per the financials filed for FY 2020, the company reported a revenue of ₹37.41 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹5,616 (net margin -0.2%) and EBITDA of ₹24,928 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232TG2011PTC073540
Registration Number 073540
Incorporation Date 28 March 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Claro Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC073540. The current CIN is U24232TG2011PTC073540, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2011PTC073540Current
U24232AP2011PTC073540Previous

Contact details

Claro Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Claro Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Claro Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Claro Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Claro Pharmaceuticals Private Limited, buy the company report.

Financials of Claro Pharmaceuticals Private Limited

FY 2020 filings available

Claro Pharmaceuticals Private Limited reported revenue of ₹37.41 Lakh (up 5% YoY) for FY 2020.

Revenue · FY 2020
₹37.41 Lakh ▲ 5%
Net loss · FY 2020
₹5,616 margin -0.2%
EBITDA · FY 2020
₹24,928 margin 0.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 10%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 31%
5 years · compounded
▲ 18%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 5% growth in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹37.41 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24,928
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5,616
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin0.7%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Claro Pharmaceuticals Private Limited, buy the company report.

Board of directors of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun SinghAdditional Director21 Mar 20224 Years 8 MonthsCurrent
Chevuru KomaleswariAdditional Director09 Jan 201412 Years 10 MonthsCurrent
Chevuru HariprasadDirector16 Jul 201412 Years 4 MonthsCurrent

Auditor

Claro Pharmaceuticals Private Limited is audited by MANORANJAN REDDY AND ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
MANORANJAN REDDY AND ASSOCIATESFY 2019018057S

Shareholding

The shareholding of Claro Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Claro Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Claro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Claro Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAECC4747M1ZATelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Claro Pharmaceuticals Private Limited, buy the company report.

Recent activity

Claro Pharmaceuticals Private Limited has 11 board changes on record since 2014: 3 appointments and 8 cessations. The latest: Arun Singh was appointed as Additional Director on 21 Mar 2022.

Appointed
Arun Singh was appointed as Additional Director.
Ceased
Madana Mohan Reddy Ketham ceased to be Director.
Ceased
Rafayathunnisa Sunar ceased to be Director.
Ceased
Sai Eswar Rao Mahendrakar ceased to be Director.
AGM
Claro Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Claro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Ceased
Srinivasa Rao Penugonda ceased to be Director.
Ceased
Chunchu Murali Krishna ceased to be Director.
Ceased
Kodukula Satesh Kumar ceased to be Additional Director.
Appointed
Chevuru Hariprasad was appointed as Director.
Ceased
Chevuru Hariprasad ceased to be Director.
Appointed
Chevuru Komaleswari was appointed as Additional Director.

2 earlier events are in the company report.

Frequently asked questions

Claro Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U24232TG2011PTC073540.

Claro Pharmaceuticals has 3 current directors:

The latest financial statements of Claro Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Claro Pharmaceuticals is 36AAECC4747M1ZA, registered in Telangana.

The CIN (Corporate Identification Number) of Claro Pharmaceuticals is U24232TG2011PTC073540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Claro Pharmaceuticals was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.

Arun Singh was appointed as Additional Director on 21 Mar 2022. Madana Mohan Reddy Ketham ceased to be Director on 21 Mar 2022. Rafayathunnisa Sunar ceased to be Director on 21 Mar 2022. Claro Pharmaceuticals has 11 board changes on record in total.

The registered office of Claro Pharmaceuticals is at 16 – 2 – 7531192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.

Claro Pharmaceuticals operates in the healthcare industry, in the medical and laboratory equipment segment.

The compliance status of Claro Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.